New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 3, 2013
10:00 EDTMNK, ASGN, ECL, FOXA, CLDX, ROL, MAN, CTAS, MMLP, RHI, GMT, CQPOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: 21st Century Fox (FOXA) initiated with a Buy at Needham... Cheniere Energy Partners (CQP) initiated with an Outperform at RBC Capital... Cintas (CTAS) initiated with an Outperform at RBC Capital... Ecolab (ECL) initiated with an Outperform at RBC Capital... GATX Corp. (GMT) initiated with an Equal Weight at Stephens... Manpower (MAN) initiated with a Sector Perform at RBC Capital... On Assignment (ASGN) initiated with an Outperform at RBC Capital... Robert Half (RHI) initiated with an Outperform at RBC Capital... Rollins (ROL) initiated with a Sector Perform at RBC Capital... Mallinckrodt (MNK) initiated with a Buy at BofA/Merrill... Martin Midstream Partners (MMLP) initiated with a Neutral at BofA/Merrill... Celldex (CLDX) initiated with a Buy at Guggenheim.
News For FOXA;CQP;CTAS;ECL;GMT;MAN;ASGN;RHI;ROL;MNK;MMLP;CLDX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
March 23, 2015
07:54 EDTECLEcolab management to meet with Deutsche Bank
Subscribe for More Information
March 22, 2015
18:46 EDTFOXALionsgate's 'The Insurgent' takes top spot at box office with $54M
Subscribe for More Information
March 20, 2015
09:32 EDTMMLPMartin Midstream Partners to host analyst and investor day
Analyst and Investor day will be held in Houston on March 24 at 10 am. Webcast Link
March 19, 2015
10:23 EDTCTASHigh option volume stocks
Subscribe for More Information
10:02 EDTROLOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:20 EDTROLRollins initiated with an Outperform at Macquarie
Subscribe for More Information
07:04 EDTFOXAAmerican Express confirms plans to launch Plenti loyalty program
Subscribe for More Information
March 18, 2015
18:32 EDTCTASOn The Fly: After Hours Movers
UP AFTER EARNINGS: Guess (GES), up 12.4% after reporting fourth quarter results and guidance... Shoe Carnival (SCVL), up 10%... NQ Mobile (NQ), up 9.1%... Tilly's (TLYS), up 1.3%... Cintas (CTAS), up 1.3% after reporting quarterly results and raising fiscal 2015 guidance. DOWN AFTER EARNINGS: Williams-Sonoma (WSM), down 4.1%... Jabil Circuit (JBL), down 1.8%... Juno Therapeutics (JUNO), down 3.3%. ALSO LOWER: Concert Pharmaceuticals (CNCE), down 4.4% after filing to sell common stock... Tekmira Pharmaceuticals (TKMR), down 3.7% after filing to sell 6M shares of common stock.
17:01 EDTCTASCintas raises FY15 EPS view to $3.31-$3.34 from $3.20-$3.25, consensus $3.27
Subscribe for More Information
16:31 EDTCTASCintas sees FY15 EPS $3.31-$3.34, consensus $3.27
Subscribe for More Information
16:27 EDTCTASCintas reports Q3 EPS 85c, consensus 78c
Reports Q3 revenue $1.11B, consensus $1.11B.
15:20 EDTCTASNotable companies reporting after market close
Subscribe for More Information
12:09 EDTFOXASony announces launch of PlayStation Vue in New York, Chicago, Philadelphia
Subscribe for More Information
09:23 EDTFOXAVerizon may launch mobile TV service as soon as June, Bloomberg says
Verizon (VZ) has secured mobile television streaming rights with Viacom (VIA, VIAB) and DreamWorks Animation (DWA) and plans to start a mobile video streaming service as early as June, according to Bloomberg, citing a person familiar with the matter. Verizon plans to have programming from ABC (DIS), NBC (CMCSA), CBS (CBS) and Fox (FOXA) as part of the service, the report added. The Fly notes that Verizon has publicly confirmed previously that it plans to launch such a service, but has not provided many details to date.
06:16 EDTFOXAAmerican Express to launch Plenti loyalty program this spring, WSJ reports
Subscribe for More Information
March 17, 2015
13:06 EDTFOXABattleground: Analysts take opposite sides on Netflix
Subscribe for More Information
11:37 EDTCTASCintas March volatility elevated into Q3 and outlook
Subscribe for More Information
11:36 EDTFOXAApple may launch standalone TV in 2016, says Piper Jaffray
Subscribe for More Information
09:25 EDTCLDXOn The Fly: Pre-market Movers
Subscribe for More Information
08:13 EDTCLDXCelldex announces clinical trial collaboration with Roche
Celldex Therapeutics (CLDX) announced that it has entered into a clinical trial collaboration with Roche (RHHBY) to evaluate the safety, tolerability and preliminary efficacy of varlilumab, Celldex's CD27 targeting investigational antibody, and MPDL3280A, Roche's investigational cancer immunotherapy in a Phase 1/2 study in renal cell carcinoma. Varlilumab and MPDL3280A are part of a new class of investigational medicines known as cancer immunotherapies that are designed to harness the body's own immune system to fight cancer through separate yet complementary mechanisms of action that may enable the activation of T cells, restoring their ability to effectively detect and attack tumor cells. Preclinical data suggest the combination of these two mechanisms are synergistic and may enhance anti-tumor immune response compared to either agent alone. In Celldex's Phase 1 study of varlilumab in multiple solid tumors, promising signs of clinical activity in patients with refractory renal cell carcinoma were observed, including a durable partial response that has continued to decrease in tumor volume over time and prolonged stable disease. Under the terms of this agreement, Roche will provide study drug and Celldex will be responsible for conducting and funding the study, which is expected to begin in 2015.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use